Diagnostic Testing Procedures in Urodynamics V3.0

Size: px
Start display at page:

Download "Diagnostic Testing Procedures in Urodynamics V3.0"

Transcription

1 V

2 Table of Contents Summary Introduction Diagnostic testing information Purpose of this Policy/Procedure Approved Document Process Scope Who the policy applies to Definitions / Glossary Ownership and Responsibilities Role of the Managers Role of Individual Staff Standards and Practice Content Diagnostic tests provided by the service How diagnostic testing procedures are risk assessed Measures that need to be in place Identifying the process How the diagnostic test is requested Clinician - Results and Timescales Patient Results and Timescales Actions to be taken by the clinician, including timescales How the minimum requirements for NHSLA are recorded Dissemination and implementation (including education and training) Monitoring compliance and effectiveness Updating and Review Equality and Diversity... 9 Appendix 1. Governance Information Appendix 2. Initial Equality Impact Assessment Form Page 2 of 13

3 1. Introduction 1.1. Diagnostic testing information Diagnostic testing information supports many clinical decisions both in the identification of new conditions and the monitoring and treatment of existing ones. As such it sits within the overall patient clinical pathway. The diagnostic pathway begins when a test is indicated such that a request is generated, progresses via the diagnostic process and ends when a report is received by the requester and acted upon. Failures at any point in this pathway may lead to delays in the care of the patient, sometimes with serious clinical consequences. 2. Purpose of this Policy/Procedure 2.1. Approved Document Process This policy sets out an approved documented process whereby the risks associated with diagnostic testing procedures within Urology are managed through the provision of local policies and procedures which are implemented and monitored. It has been developed to ensure these risks are minimised and give assurance to external bodies. No patient s treatment should be delayed because of delays in the availability of Diagnostic information and the objective of this document is to ensure that this does not happen, recognising that communication problems are often the root of such delays; there is an absolute need for clear pathways that identify how, when and to whom the results should be communicated. This policy is aimed at those who provide and those who use the Respiratory services. 3. Scope 3.1. Who the policy applies to This policy applies to all those who request Urodynamics diagnostic tests and those who receive, process or need to act on the results of these. 4. Definitions / Glossary NHSLA: National Health Service Litigation Authority CITS: Cornwall IT Services DBMS: Database Management section within CITS GP: General Practitioner MAXIMS: Electronic clinical record system designed by IMS (Irish Medical Systems) RCHT: Royal Cornwall Hospitals NHS Trust 5. Ownership and Responsibilities 5.1. The strategic and operational roles responsible for the development, management and implementation of the policy are shown below. Page 3 of 13

4 5.2. Role of the Managers Conducting stringent recruitment checks to ensure that only appropriately qualified and registered staff undertake and authorise test results and on-going checks of professional registration On-going checks of training and competence to perform those tests within the scope of activity of individual staff Ensuring that staff follow those processes and procedures described in the standards and practice section relevant to the part they play in the diagnostic pathway Role of Individual Staff The diagnostic pathway begins when a request is generated and any samples required are taken; it progresses via the diagnostic testing process and ends when a report is received by the requester and acted upon. Various healthcare staff are involved in this pathway including Doctors, Nurses, Healthcare Assistants/Support workers and Professions Allied to Medicine (Biomedical Scientists, Radiographers etc.) Administrative staff have an important role in ensuring that, for paper based reporting systems, all results are communicated to the clinical staff in charge of the patient Administrative staff also have a role to play in ensuring appointments are booked and appropriate preparation instigated in accordance with agreed operating policies Laboratory based administrative staff ensure that any paper reports are despatched in a timely manner All staff members are responsible for: Being aware of this policy and any documents referred to within it pertaining to their part in the diagnostic pathway. Adhering to any requirements described within this policy and documents described in the standards and practice section pertaining to their role in the diagnostic pathway. 6. Standards and Practice 6.1. Content The content of this section takes account of the information provided in the overarching Trust-wide policy which in turn is informed by the document and template provided by the NHSLA (amended to incorporate revisions to the Standards in January 2012) for Standard 5 Criterion 7: Diagnostic Testing Procedures, and is used to provide details and information describing the practices, systems, and processes staff are expected to follow in order to comply with this document. Page 4 of 13

5 6.2. Diagnostic tests provided by the service The Urodynamics Department provides two forms of diagnostic tests: Flow Test Invasive Urodynamic Test 6.3. How diagnostic testing procedures are risk assessed Departments need to focus on the degree of intervention required, the consequence of missed diagnosis and the impact for the Trust. Information sources include a trawl of the complaints, claims and incidents data to see if there are common themes as this would also indicate an area of increased risk for the organisation Diagnostic testing procedures are evaluated at the time of introduction (e.g. to check that the procedure is fit for purpose ). Risk assessment tends to be reactive to changes such as the introduction of new guidelines or equipment or changes to existing equipment (e.g. with age) which require that the current level of risk is assessed All Urodynamics investigations are vetted by a practitioner and a decision made to proceed on the risk v. clinical benefit Measures that need to be in place Measures that need to be in place for the diagnostic test to enable any preparation of the patient where required Where these are required, this well be indicated in user guides / requesting information or specific information provided for patients Identifying the process Identifying the process for ensuring that informed consent is obtained prior to a diagnostic test Consent for investigations is obtained by the test requester. The reader is referred to the Trust s consent policy How the diagnostic test is requested It is important that requests are generated, received and processed correctly in order for the diagnostic process to be initiated in the first place The professional expectation is that anyone requesting a test should have the training, experience and authority to explain the result to the patient. The Urodynamics Department has a duty to carry out reasonable tests on the assumption that they have been legitimately requested. Page 5 of 13

6 Urodynamics Flow Tests can be requested either directly by the patient s GP or as a result of contact with the Urology Department. On receipt of the flow test request the patient will be scheduled into an appropriate flow test clinic run by a urology clinical nurse specialist Invasive Urodynamics Tests performed in the Urology Department are only requested by a Urology Consultant Clinician - Results and Timescales How the clinician treating the patient is informed of the result, including timescales On receipt of the diagnostic test results in the Urology Clinic, the results are photocopied and dealt with as follows: Original copy sent to the clinician treating the patient One copy filed in patient health record if the patient is being treated via the Urology Clinic Copy is scanned and placed as patient document in MAXIMS The clinician treating the patient is responsible for ensuring that they have received the results for their patient. All correspondence is filed both in MAXIMS and the patient s health record For invasive Urodynamics test the clinician who has requested the test will be informed of the results by dictated letter. Test recordings / traces are scanned onto MAXIMS to accompany the letter. If the clinician requesting the test has also carried out the test a letter documenting the results will be dictated and sent to the GP Every result should be finally marked off as checked by the requesting clinician The Urodynamics Department endeavours to provide test results to the requesting clinician within 7 days however, GP letters are sent electronically Patient Results and Timescales How the patient is informed of the result, including timescales Patients must be made aware of the reason for the tests being requested and the approximate timescale and communication method availability of the results so that they may request an update on results as necessary. Results which have significant implication for the patient must be discussed with them in the appropriate timescale There is an expectation that patients are informed of results by the requesting clinician in a timely fashion. It is the responsibility of the requester to consider how, when and what to tell the patient. Page 6 of 13

7 The mechanisms and timescales for informing patients of results are the responsibility of the requesting clinician but may include, according to the nature of the test, availability of result and the significance of the result. Telling patients Writing to patients Discussing with patient s GP Writing to their GP Telephone call Adding to discharge summary Every opportunity should be taken to check for / flag outstanding results including at hospital discharge, outpatient and GP appointments Actions to be taken by the Clinician, including timescales The person receiving the results should ensure the results are brought to the attention (urgently if necessary) of the clinical team currently caring to for the patient. Results should be reviewed by a person with clinical responsibility for the patient who is able to interpret the results and ensure a management plan is recorded as required. The clinician requesting the test is to ensure that the patient has been informed of the results The requesting Consultant will take responsibility for ALL investigations requested by them or in their name, but the responsibility for signing off a result can be appropriately delegated. In MAXIMS results default to going back to the Consultant who is in charge of the patient, under whose name the tests are requested. However, the person who actually requested the test can also search under their name and find the result The requesting Clinician is responsible for reviewing any urgent results requested during their shift and passing the responsibility on if they finish their shift. For those tests that are requested but the patient has moved on to another area when the test is done or the result is available, responsibility for the results passes to the clinician responsible for the patient in that area It is incumbent on the responsible clinician to ensure that he or she personally checks the reporting systems on a regular basis for the investigation results and then acts on the information within the report with the necessary degree of urgency. If they are unable to do this they must hand the responsibility over to a colleague. Failure to do this may put patients at risk Safety net procedures must be established by requesters, to ensure high risk diagnoses and results are not inadvertently missed. The procedure must take account of patients moving from area to area within a hospital and being discharged before results are received. Page 7 of 13

8 6.10.How the minimum requirements for NHSLA are recorded Requesting All Urodynamics test requests are recorded in the patient s health record Informing the clinician At present test results are photocopied and filed in the patient s health record and the results are also scanned into MAXIMS as a patient document. When full functionality is achieved in MAXIMS every result will have to be finally marked off as checked Informing the patient Records are kept of any written correspondence with the patient or their Doctor in the patient s health record Actions taken Actions taken are documented in the notes. When recording results within the patient s record the minimum information which must be included is: o o o o o Forename and surname NHS / Hospital number Test or procedure Date and time investigation was performed Interpretive comments made / conclusion reached may be recorded The method of communication of the actions must be recorded, i.e. face to face contact, phone call, letter, s, fax, etc. Hospital discharge summaries should record confirmed diagnosis and any outstanding investigations. 7. Dissemination and implementation (including education and training) 7.1. This document will be placed on the Cornwall & Isles of Scilly Health Community Documents Library with notification of all users via . Page 8 of 13

9 8. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements 1. Informing the clinician treating the patient of the result; ensuring they are looked at/acknowledged. 2. Acting on, documenting & Informing the patient of the result. Consultant Urologist Monitoring of incidence of non-availability of test results when the patient attends clinic. Six Monthly. For a one week period every six months the Urodynamics Department administrators will use consultant notes to identify those instances where a patient has attended clinic but their test results were not available. The results of this monitoring will be recorded by the Urodynamics Department administrators and reported to the Governance and Management Committees. Each report should contain a summary and action points to enable these to be readily identified; these should be discussed and recorded in meeting minutes. Acting on recommendations and Lead(s) Change in practice and lessons to be shared The lead or committee is expected to read and interrogate the report to identify deficiencies in the system and act upon them. The Committee which reviews the report will delegate recommendations and action planning, for any or all deficiencies and recommendations within reasonable timeframes, to the appropriate committee, department or lead. Required actions will be identified and completed in a specified timeframe. Required changes to practice will be identified and actioned within the minimum achievable timescale. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders. 9. Updating and Review 9.1. This policy will be reviewed every three years or sooner if circumstances suggest this may be necessary. 10. Equality and Diversity 10.1.This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website A completed Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 9 of 13

10 Appendix 1. Governance Information Document Title Date Issued/Approved: 16 March 2016 Date Valid From: 16 March 2016 Date Valid To: 16 March 2021 Directorate / Department responsible (author/owner): Contact details: Brief summary of contents Suggested Keywords: Mr Christopher Blake, Consultant Urologist This policy sets out an approved documented process whereby the risks associated with diagnostic testing procedures in Urodynamics are managed. Diagnostic Test, Urodynamics, Urology. Target Audience RCHT PCH CFT KCCG Executive Director responsible for Policy: Medical Director Date revised: This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Specialty Governance meeting Divisional Manager confirming approval processes Name and Post Title of additional signatories Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Training Need Identified? Vicky Peverell Not Required {Original Copy Signed} Name: {Original Copy Signed} Internet & Intranet Intranet Only Clinical / Urology NHSLA Standard 5 Criterion 7: Diagnostic Testing Procedures Safer Practice Notice 16, February 2007 An Organisation-wide Policy for the Management of Diagnostic Testing Procedures Ward Telephoned Results procedure. No Page 10 of 13

11 Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) 2 Jul 12 V1.0 Initial Issue Mr Christopher Blake Consultant Urologist 16 Mar 16 V2.0 Re format into new template 09 Jan 18 V3.0 Review no change All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 11 of 13

12 Appendix 2. Initial Equality Impact Assessment Form Name of Name of the strategy / policy /proposal / service function to be assessed (hereafter referred to as policy) (Provide brief description): Diagnostic Testing Procedures in Urodynamics Directorate and service area: Is this a new or existing Policy? Diagnostics (Urodynamics) Yes Name of individual completing Telephone: assessment: Christopher Blake 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? Sets out an approved documented process whereby the risks associated with diagnostic testing procedures are managed through the provision of local policies which are implemented and monitored. 2. Policy Objectives* The risks associated with diagnostic testing procedures are minimised; compliance with NHSLA Standard 5 Criterion 7: Diagnostic Testing Procedures is achieved. 3. Policy intended Outcomes* To ensure that the diagnostic process contributes the maximum benefit to the treatment of patients. 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? As described above. All patients. No b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. Page 12 of 13

13 7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Rationale for Assessment / Existing Evidence Age Sex (male, female, transgender / gender reassignment) Race / Ethnic communities /groups Disability - Learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. No 9. If you are not recommending a Full Impact assessment please explain why. No negative impact. Signature of policy developer / lead manager / director Date of completion and submission Names and signatures of members carrying out the Screening Assessment Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed Date Page 13 of 13

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging

Diagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.

More information

Diagnostic Testing Procedures for Ophthalmic Science

Diagnostic Testing Procedures for Ophthalmic Science V4.0 01/08/17 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3.

More information

Diagnostic Testing Procedures in Neurophysiology V1.0

Diagnostic Testing Procedures in Neurophysiology V1.0 V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the

More information

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline

Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with

More information

Policy on Governance Arrangements Relating to Medicines V2.0

Policy on Governance Arrangements Relating to Medicines V2.0 V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters

More information

Loading Dose Worksheet for Oral Amiodarone

Loading Dose Worksheet for Oral Amiodarone This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.

More information

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES

More information

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0

Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016 Summary. This policy applies only to selected staff within the Haematology Department at the

More information

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start

CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start The non-medical practitioner has received sufficient training to make clinical

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis

More information

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)

CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) 1. Aim/Purpose of this Guideline 1.1. Pain is whatever the experiencing person says it is, existing whenever the experiencing person

More information

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.

A list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department. Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist

More information

School Vision Screening Policy V2.0

School Vision Screening Policy V2.0 School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put

More information

CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of for the management of Adult patients with Mellitus

More information

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.

1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays. Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse

More information

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline

Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist

More information

Newborn Hearing Screening Programme Policy

Newborn Hearing Screening Programme Policy Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not

More information

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE

CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL GUIDELINE V4. Summary. Start The non-medical practitioner

More information

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS

CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm

More information

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its

More information

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0

The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 October 2016 Summary. Start See section 6.2 of this document for important information regarding

More information

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy

More information

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and

More information

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical

More information

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite

2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite ADVANCED NEONATAL NURSE PRACTITIONERS (ANNPs) BLOOD COMPONENT AND BLOOD PRODUCT REQUESTING PROTOCOL NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 The purpose of this protocol is to guide

More information

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0

CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 Page 1 of 13 Abbreviation (P/A)HDU (P/A)ICU GCS IPPV CPAP BiPAP DKA Reg Meaning (Paediatric/Adult) High Dependency

More information

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.

This guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin. CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing

More information

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its

More information

Tissue Viability Referral Pathway. April 2017

Tissue Viability Referral Pathway. April 2017 Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

Safe Bathing Policy V1.3

Safe Bathing Policy V1.3 V1.3 April 2018 Summary Safe hot water temperatures The hot water distribution temperatures, which are required for the control and prevention of Legionella, can lead to discharge temperatures in excess

More information

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.

2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures. Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose

More information

WARD CLOSURE POLICY V

WARD CLOSURE POLICY V WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.

More information

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0

OXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy

More information

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline

ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline 1.1. This guidance is designed to aid staff to monitor capacity and staffing in Child Health. 2. The Guidance 2.1. The majority

More information

Patient Experience Strategy

Patient Experience Strategy POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

Safeguarding Children Supervision Policy V4.0. November 2016

Safeguarding Children Supervision Policy V4.0. November 2016 Safeguarding Children Supervision Policy V4.0 November 2016 Page 1 of 20 Summary Part 1 Part 2 Safeguarding supervision for Nursing and Midwifery staff, Paediatricians, Medical Staff and other Allied Health

More information

Procedure for the Application of a Cast and its subsequent care V1.3

Procedure for the Application of a Cast and its subsequent care V1.3 Procedure for the Application of a Cast and its subsequent care V1.3 May 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...

More information

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND

CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND 1. Aim/Purpose of this Guideline The aim of this guideline to enable the effective care of patients needing emergency defill of

More information

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 This guideline aimed at all clinical staff responsible for the management of infants

More information

Occupational Health Surveillance Policy V2.1

Occupational Health Surveillance Policy V2.1 Occupational Health Surveillance Policy V2.1 May 2016 Table of Contents 1. Introduction... 2 2. Purpose of this Policy... 2 3. Scope... 2 4. Definitions/Glossary... 3 5. Ownership and Responsibilities...

More information

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0

Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 January 2016 Summary Purpose of the document: The purpose of this policy is to provide an outline of the requirements

More information

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0

PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline

More information

CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline

CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the operation and interpretation of Cerebral Function Monitoring (CFM) in neonates.

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction

More information

Severe Weather Plan V5.5 March 2018

Severe Weather Plan V5.5 March 2018 V5.5 March 2018 Table of Contents 1. Introduction 3 2. Purpose of this Plan. 3 3. Scope. 3 4. Ownership and Responsibilities. 3 5. Escalation Levels and Actions 5 6. Staffing Contingency and Guidance.

More information

RCHT Non-Ionising Radiation Safety Policy

RCHT Non-Ionising Radiation Safety Policy V3.0 June 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 4 4. Definitions / Glossary... 5 5. Ownership and Responsibilities... 5 6. Standards and Practice...

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017

More information

Management of Diagnostic Testing and Screening Procedures Policy

Management of Diagnostic Testing and Screening Procedures Policy Trust Policy Management of Diagnostic Testing and Screening Procedures Policy Purpose Date Version July 2012 2 The purpose of this policy is to ensure that all diagnostic and screening tests undertaken

More information

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017

Safe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017 Safe Staffing Levels for Midwifery, Nursing and Support Staff For Maternity Service - Approved V1.5 June 2017 Jan Walters Head of Midwifery Women, Children and Sexual Health Division CONTENTS Section Page

More information

NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY

NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY PLEASE NOTE POLICY IS UNDER REVIEW NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY Target Audience Brief Description (max 50 words) Action Required Providers, Commissioners

More information

DATA PROTECTION ACT (1998) SUBJECT ACCESS REQUEST PROCEDURE

DATA PROTECTION ACT (1998) SUBJECT ACCESS REQUEST PROCEDURE DATA PROTECTION ACT (1998) SUBJECT ACCESS REQUEST PROCEDURE Date effective from: 1 st September 2014 Review date: 1 st September 2017 Version number: 4.0 See Document Summary Sheet for full details Date

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019

More information

Hand Hygiene Policy V2.1

Hand Hygiene Policy V2.1 V2.1 October 2017 Summary. Effective hand hygiene is shown to significantly reduce the carriage of potential pathogens and decrease the risk and occurrence of healthcare associated infections. Each individual

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Named Key Worker for Cancer Patients Policy Version No.: 4 Effective 07 December 2017 From: Expiry Date: 07 December 2020 Date Ratified: 17 October

More information

New Clinical Interventional Procedures Policy

New Clinical Interventional Procedures Policy New Clinical Interventional Procedures Policy Policy Title: Executive Summary: New Clinical Interventional Procedures Policy This document sets out East Cheshire NHS Trust s policy to ensure compliance

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for Monitoring of Delayed Transfers of Care Version No.: 2.2 Effective From: 17 March 2015 Expiry Date: 17 March 2018 Date Ratified: 25

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines

More information

Access to Health Records Procedure

Access to Health Records Procedure Access to Health Records Procedure Version: 1.0 Ratified by: Date ratified: 11/03/2015 Name of originator/author: Name of responsible individual: Information Governance Group Medical Records Manager, Jackie

More information

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines

Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Document Number Version Ratified By & Date Name of Approving Body(s) & Date(s) FPE-004 V1 Safety and Effectiveness Sub-Committee

More information

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0

Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing

More information

MORTALITY REVIEW POLICY

MORTALITY REVIEW POLICY MORTALITY REVIEW POLICY Version 1.3 Version Date July 2017 Policy Owner Medical Director Author Associate Director of Patient Safety & Quality First approval or date last reviewed July 2017 Staff/Groups

More information

CLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance The Newcastle upon Tyne Hospitals NHS Foundation Trust Patient Choice Directive Policy & Guidance Version No.: 2.1 Effective From: 26 August 2014 Expiry Date: 26 August 2016 Date Ratified: 17 June 2014

More information

Document Title: Recruiting Process. Document Number: 011

Document Title: Recruiting Process. Document Number: 011 Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs)

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs) The Newcastle Upon Tyne Hospitals NHS Foundation Trust Use of Patients Own Drugs (PODs) Version.: 2.2 Effective From: 20 January 2016 Expiry Date: 20 January 2019 Date Ratified: 13 January 2016 Ratified

More information

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy

More information

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed: Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy

More information

This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services

This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services Patient Access Policy November 2013 This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services Version: 1.0 Policy reference

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust

The Newcastle upon Tyne Hospitals NHS Foundation Trust The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for registration and supply of prophylaxis to the immediate household contacts of patients admitted with meningococcal disease Version.:

More information

CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary.

CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary. CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary. Start Elective procedure identified, blood requirement listed in guideline Patient attends PAC and has a group and screen (G&S)

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry

More information

Animals and Pets in Healthcare Facilities Policy

Animals and Pets in Healthcare Facilities Policy Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,

More information

Policy Summary. Policy Title: Policy and Procedure for Clinical Coding

Policy Summary. Policy Title: Policy and Procedure for Clinical Coding Policy Title: Policy and Procedure for Clinical Coding Reference and Version No: IG7 Version 6 Author and Job Title: Caroline Griffin Clinical Coding Manager Executive Lead - Chief Information and Technology

More information

Patient Identification

Patient Identification Patient Identification Reference No: Version: 5 Ratified by: P_CS_24 LCHS Trust Board Date ratified: 10 th April 2018 Name of originator/author: Name of approving committee/responsible individual: Date

More information

Executive Director of Nursing and Chief Operating Officer

Executive Director of Nursing and Chief Operating Officer Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15

More information

Lone worker policy. Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead

Lone worker policy. Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead Document level: Trustwide (TW) Code: GR33 Issue number: 3 Lone worker policy Lead executive Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead 01244 397618

More information

RECEIPT & SCRUTINY OF MENTAL HEALTH ACT PAPERS

RECEIPT & SCRUTINY OF MENTAL HEALTH ACT PAPERS SECTION: 8.0 - MENTAL HEALTH LEGISLATION POLICY AND PROCEDURE NO: 8.07 NATURE AND SCOPE: SUBJECT: POLICY & PROCEDURE - TRUSTWIDE RECEIPT & SCRUTINY OF MENTAL HEALTH ACT PAPERS This policy/procedure relates

More information

Provision of Wigs Policy

Provision of Wigs Policy Post holder responsible for Procedural Document Author and post holder of Policy Division/Department responsible for Procedural Document Contact details Lead Cancer Nurse Tina Grose, Lead Cancer Nurse

More information

NHS Continuing Healthcare Choice Policy Supporting people in Dorset to lead healthier lives

NHS Continuing Healthcare Choice Policy Supporting people in Dorset to lead healthier lives NHS Dorset Clinical Commissioning Group NHS Continuing Healthcare Choice Policy Supporting people in Dorset to lead healthier lives 1 PREFACE The purpose of this policy is to balance patient preference

More information

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY

DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Protected Mealtime Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Protected Mealtime Policy Version No 3 Effective From 12 February 2018 Expiry date 12 February 2021 Date Ratified 01 November 2017 Ratified By Nutritional

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Key Control Operational Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Key Control Operational Policy Version.: 1.0 Effective From: 18 January 2016 Expiry Date: 18 January 2019 Date Ratified: 22 December 2015 Ratified

More information

Section 19 Mental Health Act 1983 Regulations as to the transfer of patients

Section 19 Mental Health Act 1983 Regulations as to the transfer of patients Document level: Trustwide (TW) Code: MH9 Issue number: 4 Section 19 Mental Health Act 1983 Regulations as to the transfer of patients Lead executive Authors details Type of document Target audience Document

More information

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified

More information

GCP Training for Research Staff. Document Number: 005

GCP Training for Research Staff. Document Number: 005 GCP Training for Research Staff Document Number: 005 Version: 1 Ratified by: RFL Committee Date ratified: 03.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Ventilation Policy Version.: 1.0 Effective From: 15 January 2016 Expiry Date: 15 January 2019 Date Ratified: 22 December 2015 Ratified By: Estates

More information

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:

POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health

More information

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY

DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY Document Title: DISCLOSURE OF CERVICAL CANCER SCREENING AUDIT RESULTS POLICY Document Reference/ Register no: 18015 Version Number: 1.0 Document type: Policy To be followed by: Cervical Screening Provider

More information

Freedom to speak up: raising concerns (whistleblowing) policy

Freedom to speak up: raising concerns (whistleblowing) policy Freedom to speak up: raising concerns (whistleblowing) policy When using this document please be sure that the version you are using is the most up to date either by checking on the Trust intranet or if

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:

More information

Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS)

Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS) Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS) Policy Title: Executive Summary: Policy for the Management of Safety Alerts issued via the Central Alerting System

More information

NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015

NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015 NURSES HOLDING POWER SECTION 5(4) MENTAL HEALTH ACT 1983 NOVEMBER 2015 This policy supersedes all previous policies for Nurses Holding Power Section 5(4) MHA 1983. 1 Policy title Nurses Holding Power Section

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified

More information

Helicopter Landing Site (HLS) Policy, Procedure and Guidance (HSP025) V2.0

Helicopter Landing Site (HLS) Policy, Procedure and Guidance (HSP025) V2.0 Helicopter Landing Site (HLS) Policy, Procedure and Guidance (HSP025) V2.0 May 2016 Summary Process for the notification of works that may require closure of the ED Helipad Project Manager (PM) identifies

More information

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:

More information

Moving and Handling Policy

Moving and Handling Policy Moving and Handling Policy Ratified Quality, Patient Safety and Risk / 16/04/2014 / 2014-40 Status Ratified Issued April 2014 Approved By Quality, Patient Safety and Risk Committee Consultation Quality,

More information